Is octreotide useful for hepatic metastases due to non-neuroendocrine primary tumors?
Pistevou-Gombaki
PG
Kiki
Eleftheriadis
E
Nikos
Sofroniadis
S
Ioannis
Kouloulias
K
Vassilis
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000473:pathology; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008175:Lung Neoplasms / Q000473:pathology*; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000473:pathology; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide